Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545298 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
A Phase 2 study, sponsored by Nitric BioTherapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00545298: Clinical Trial Phase 2 study, sponsored by Nitric BioTherapeutics.
NCT00545298 is a Phase 2 study that was terminated before completion, run by Nitric BioTherapeutics. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00545298, a Phase 2 study, was terminated before completion, sponsored by Nitric BioTherapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers
Primary Outcome
% Re-epithelialization
Interventions
- DRUG Nitric Oxide - same dose 6 wks
- DRUG Nitric Oxide modified treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-11 |
| Phase | Phase 2 |
Why NCT00545298 stopped before completion
NCT00545298 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Nitric Oxide - same dose 6 wks is the first listed.
NCT00545298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00545298 about?
NCT00545298 is a clinical study titled "Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers". This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers
What is the current status of trial NCT00545298?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2007-10. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00545298?
The interventions under investigation include: Nitric Oxide - same dose 6 wks (DRUG), Nitric Oxide modified treatment (DRUG).
Who is sponsoring clinical trial NCT00545298?
This trial is sponsored by Nitric BioTherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00545298's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia